Renaissance Technologies - CANCER GENETICS INC ownership

CANCER GENETICS INC's ticker is CGIXXXXX and the CUSIP is 13739U104. A total of 25 filers reported holding CANCER GENETICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of CANCER GENETICS INC
ValueSharesWeighting
Q3 2019$391,000
-13.7%
3,795,263
+36.7%
0.00%
Q2 2019$453,000
-6.0%
2,777,125
+38.4%
0.00%
Q1 2019$482,000
+119.1%
2,007,229
+120.9%
0.00%
Q4 2018$220,000
-68.7%
908,714
+34.6%
0.00%
-100.0%
Q3 2018$702,000
-46.7%
675,200
-36.8%
0.00%0.0%
Q2 2018$1,317,000
+65.9%
1,068,700
+122.0%
0.00%0.0%
Q1 2018$794,000
-17.5%
481,400
-7.4%
0.00%0.0%
Q4 2017$962,000
-37.4%
519,800
-8.7%
0.00%
-50.0%
Q3 2017$1,537,000
-31.7%
569,400
-0.1%
0.00%
-33.3%
Q2 2017$2,250,000
+22.1%
569,700
+26.7%
0.00%0.0%
Q1 2017$1,843,000
+339.9%
449,600
+44.8%
0.00%
+200.0%
Q4 2016$419,000
+35.6%
310,400
+75.7%
0.00%0.0%
Q3 2016$309,000
+53.7%
176,700
+74.6%
0.00%
Q2 2016$201,000
-1.5%
101,200
+40.6%
0.00%
Q1 2016$204,000
-60.8%
71,953
-54.5%
0.00%
-100.0%
Q4 2015$521,000
-18.8%
158,000
+92.4%
0.00%
-50.0%
Q3 2015$642,000
-20.7%
82,100
+19.2%
0.00%0.0%
Q2 2015$810,000
+831.0%
68,858
+520.3%
0.00%
Q1 2015$87,000
+26.1%
11,100
+6.7%
0.00%
Q4 2014$69,00010,4000.00%
Other shareholders
CANCER GENETICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
PERKINS CAPITAL MANAGEMENT INC 806,700$2,178,0002.28%
Fairbanks Capital Management, Inc. 233,170$629,0000.61%
THOMPSON DAVIS & CO., INC. 46,975$127,0000.22%
DIKER MANAGEMENT LLC 67,055$181,0000.07%
Granahan Investment Management 237,431$641,0000.05%
HRT FINANCIAL LP 15,301$41,0000.05%
WEDBUSH SECURITIES INC 47,800$129,0000.02%
TWO SIGMA SECURITIES, LLC 14,616$39,0000.00%
Virtu Financial LLC 18,600$50,0000.00%
Renaissance Technologies 569,400$1,537,0000.00%
View complete list of CANCER GENETICS INC shareholders